Search

Displaying results 6971 - 6980 of 8517 in total
  1. Drug

    Bofutrelvir

    go.drugbank.com/drugs/DB21501
    Experimental

    Bofutrelvir has a monoisotopic molecular weight of 452.24 Da.

  2. Drug

    Ulecaciclib

    go.drugbank.com/drugs/DB21595
    Experimental

    Ulecaciclib has a monoisotopic molecular weight of 496.25 Da.

  3. Drug

    Eciruciclib

    go.drugbank.com/drugs/DB21597
    Experimental

    Eciruciclib has a monoisotopic molecular weight of 488.28 Da.

  4. Drug

    Zevotrelvir

    go.drugbank.com/drugs/DB21638
    Experimental

    Zevotrelvir has a monoisotopic molecular weight of 537.2 Da.

  5. Drug

    Orenasitecan

    go.drugbank.com/drugs/DB21718
    Experimental

    Orenasitecan has a monoisotopic molecular weight of 1470.58 Da.

  6. Drug

    Mocaciclib

    go.drugbank.com/drugs/DB21730
    Experimental

    Mocaciclib has a monoisotopic molecular weight of 609.3 Da.

  7. Drug

    Incyclinide

    go.drugbank.com/drugs/DB11647
    Investigational

    Incyclinide has been used in trials studying the treatment of HIV Infection, AIDS-related Kaposi Sarcoma, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific.

  8. Drug

    Renvistobart

    go.drugbank.com/drugs/DB19065
    Investigational

    Renvistobart is under investigation in clinical trial NCT02913313 (A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors).

    Synonyms: Anti-TIGIT Monoclonal Antibody BMS-986207
  9. Drug

    Apricoxib

    go.drugbank.com/drugs/DB12378
    Investigational

    Apricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, and Metastatic Pancreatic Cancer, among others.

  10. Drug

    Sonolisib

    go.drugbank.com/drugs/DB12601
    Investigational

    Sonolisib has been used in trials studying the treatment of Glioblastoma, Prostate Cancer, Advanced Solid Tumors, Advanced BRAF-mutant Cancers, and Non Small Cell Lung Cancer (NSCLC), among others.